CVS Health's turnaround efforts in focus amid record-high medical costs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
CVS Health (CVS) PT Raised to $76 at Truist Securities
February 13, 2025 6:04 AM ESTTruist Securities analyst David MacDonald raised the price target on CVS Health (NYSE: CVS) to $76.00 (from $60.00) while maintaining a Buy rating.
The analyst comments "We remain bullish on CVS post 4Q marked by top and bottom-line beats while 25 guidance provides an attractive baseline.... More
